Experience With the Once-Yearly Histrelin (GnRHa) Subcutaneous Implant in the Treatment of Central Precocious Puberty
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s3298
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2008
Authors
Publisher
Informa UK Limited